The Sclavo Vaccine Association (SVA) is a non-profit organization, involving 12 institutions from 6 countries, devoted to support vaccine research and development.

Based in Siena (Italy), where one of the first and most important centers in the world for vaccine vaccine development was started at the beginning of the 20th century by the visionary hygienist Achille Sclavo, the SVA is aimed at implementing an ambitious program for the development of next generation vaccines.

The sophisticated science behind the development of modern vaccines have become so complex that scientists and policy-makers need a new model for vaccine research. Today nobody can develop vaccines alone!

The overall aim of SVA is to advance the development of preventive and therapeutic vaccines, through the identification and application of novel technologies. 

SVA also aims at enhancing European competitiveness in vaccine science by promoting innovation capabilities in the area of vaccines.  Its activities are:

  • Vaccine R&D, both for high and low income countries: by organizing and coordinating national and international scientific research and development projects involving multiple organizations from private and public bodies, as well as public awareness campaigns on vaccination
  • Coordination of European Efforts in Vaccine R&D: by bringing together organizations in the vaccine area and accelerating the European Union's efforts to develop safer and more effective innovative immunization technologies
  • Standardization of immunological assays: by coordinating a project aimed at improving and standardizing the existing immunological assays, such as in the field of influenza vaccine
  • Policy making: SVA is actively involved in policy activities relating to vaccination,  by interacting with the social and scientific community at national and international levels.


Sclavo Vaccines Association

Associate Members

12 institutions from 6 EU countries, link.



Project Coordinator

SVA has an outstanding experience in the coordination and management of EU projects, FP7 and H2020. Currently SVA is the Coordinator of 4 international research projects, link.


Sclavo Vaccines Association

Via Fiorentina,1 (Administrative Offices)

Piazza La Lizza 7 (Legal Address)

53100 Siena, Italy



Business Registration Number*: 92049180521

(*NO VAT subject)

News News

Vaccini. La ricerca per la salute globale

Conference on “Vaccini. La ricerca per la salute globale” in the context of the series of meetings “ Studium ”; Siena, Aula Magna storica del Rettorato, 30 th May at 17.00. For more...

Transforming Vaccinology

Transforming Vaccinology (L2) Scientific Organizers: Rino Rappuoli, Lynda M. Stuart and Federica Sallusto March 15—19, 2020 Firenze Fiera- Fortezza da Basso, Florence,...

Advanced Course in Flow Cytometry Applied to Vaccinology

From 11 th -14 th  September 2017 , Siena, Italy.  Organized by the University of Siena and directed by Dr . Sandra Nuti.     The advanced course in flow cytometry...

Dose-dependent plasma signature of innate immune responses to the rVSV-ZEBOV vaccine reflects its biological outcomes and safety

VSV-EBOVAC Consortium reports that a dose-dependent plasma signature of innate immune responses to the rVSV-ZEBOV vaccine reflects its biological outcomes and safety in Europe and Africa ...

ADITEC presented as success story at the European Parliament

The  ADITEC Project on Advanced Immunization Technologies: an European  Success Story.   30 million Euros of funding,  42 public and private...

The European Parliament holds an event on "Vaccine Research and Development in Europe" highlighting the ADITEC success story

The Science and Technology Options Assessment (STOA) of the European Parliament, organizes an event "Working Breakfast on Vaccine Research and Development in Europe".  This is a great...

Event at the Italian Embassy in Brussels dedicated to ADITEC

A special high level event will be organized at the Italian Embassy in Brussels on the 8 th of  November. The event, will be dedicated to the High Impact Project ADITEC on the occasion of...